Skip to main content
Clinical Trials/NCT04881526
NCT04881526
Completed
Not Applicable

Ketone Ester Supplementation on Neuro-cardiovascular Responses to Stress in Humans

University of Guelph1 site in 1 country19 target enrollmentStarted: June 1, 2021Last updated:
ConditionsKetosis

Overview

Phase
Not Applicable
Status
Completed
Enrollment
19
Locations
1
Primary Endpoint
Muscle sympathetic nerve activity

Overview

Brief Summary

Ketone ester supplementation has become increasingly popular as an athletic supplement. However, the metabolic effects of these supplements on exercise performance are controversial. One potential reason for lack of an ergogenic benefit could be the effects of ketone bodies on other bodily systems, such as the sympathetic nervous system. During exercise and stress the body increases the activity of the sympathetic nervous system. This causes blood vessels to constrict (get smaller) and can increase blood pressure. Studies have shown that ketone bodies can suppress the sympathetic nervous system in mice. Additionally, ketone ester supplementation can reduce blood pressure in healthy adults. In humans, direct measures of sympathetic activity are usually made from sympathetic outflow to muscle, also called muscle sympathetic nerve activity (MSNA). Using a ketone ester supplement, the investigators plan to measure blood pressure and sympathetic outflow to muscle at rest and during handgrip exercise and a mathematical task stress test to investigate the effect of ketones on neuro-cardiovascular stress responses.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Double (Participant, Investigator)

Masking Description

Double-blind

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 18 to 40 years of age
  • Healthy, free of known cardiovascular, metabolic, or musculoskeletal disease

Exclusion Criteria

  • History of smoking (within 3 months), diagnosed cardiovascular or metabolic disease, recent musculoskeletal injury preventing handgrip exercise, prescription of chronic medications other than oral contraceptives.
  • Current or recent (within 6 months) use of ketone ester supplementation or participation in a ketogenic diet.
  • Inability to abstain from drugs, caffeine, alcohol, or strenuous physical activity prior to the study visit.

Outcomes

Primary Outcomes

Muscle sympathetic nerve activity

Time Frame: Post-intervention - Immediately following active and control interventions

Microneurography of fibular nerve

Blood pressure

Time Frame: Post-intervention - Immediately following active and control interventions

Finger plethysmography

Secondary Outcomes

  • Forearm blood flow(Post-intervention - Immediately following active and control interventions)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Philip Millar

Associate Professor

University of Guelph

Study Sites (1)

Loading locations...

Similar Trials